ExodusPoint Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-9,952
| Closed | -$1.79M | – | 1651 |
|
2025
Q1 | $1.79M | Buy |
9,952
+191
| +2% | +$34.4K | 0.02% | 679 |
|
2024
Q4 | $1.53M | Buy |
+9,761
| New | +$1.53M | 0.01% | 746 |
|
2024
Q3 | – | Sell |
-14,892
| Closed | -$2.74M | – | 1728 |
|
2024
Q2 | $2.74M | Sell |
14,892
-3,380
| -18% | -$621K | 0.02% | 565 |
|
2024
Q1 | $3.25M | Sell |
18,272
-24,230
| -57% | -$4.31M | 0.02% | 441 |
|
2023
Q4 | $5.27M | Buy |
42,502
+14,752
| +53% | +$1.83M | 0.03% | 298 |
|
2023
Q3 | $3.22M | Buy |
27,750
+3,649
| +15% | +$423K | 0.03% | 469 |
|
2023
Q2 | $2.83M | Sell |
24,101
-112,040
| -82% | -$13.2M | 0.02% | 595 |
|
2023
Q1 | $10.9M | Buy |
136,141
+30,380
| +29% | +$2.43M | 0.09% | 200 |
|
2022
Q4 | $8.38M | Buy |
105,761
+40,975
| +63% | +$3.25M | 0.12% | 202 |
|
2022
Q3 | $4.52M | Buy |
64,786
+43,720
| +208% | +$3.05M | 0.06% | 413 |
|
2022
Q2 | $1.38M | Buy |
+21,066
| New | +$1.38M | 0.02% | 898 |
|
2019
Q2 | – | Sell |
-17,648
| Closed | -$581K | – | 1206 |
|
2019
Q1 | $581K | Buy |
+17,648
| New | +$581K | 0.04% | 282 |
|